Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2001-12-19
pubmed:databankReference
pubmed:abstractText
Glutarylamidase is an important enzyme employed in the commercial production of 7-aminocephalosporanic acid, a starting compound in the synthesis of cephalosporin antibiotics. 7-aminocephalosporanic acid is obtained from cephalosporin C, a natural antibiotic, either chemically or by a two-step enzymatic process utilizing the enzymes D-amino acid oxidase and glutarylamidase. We have investigated possibilities for redesigning glutarylamidase for the production of 7-aminocephalosporanic acid from cephalosporin C in a single enzymatic step. These studies are based on the structures of glutarylamidase, which we have solved with bound phosphate and ethylene glycol to 2.5 A resolution and with bound glycerol to 2.4 A. The phosphate binds near the catalytic serine in a way that mimics the hemiacetal that develops during catalysis, while the glycerol occupies the side-chain binding pocket. Our structures show that the enzyme is not only structurally similar to penicillin G acylase but also employs essentially the same mechanism in which the alpha-amino group of the catalytic serine acts as a base. A subtle difference is the presence of two catalytic dyads, His B23/Glu B455 and His B23/Ser B1, that are not seen in penicillin G acylase. In contrast to classical serine proteases, the central histidine of these dyads interacts indirectly with the O(gamma) through a hydrogen bond relay network involving the alpha-amino group of the serine and a bound water molecule. A plausible model of the enzyme-substrate complex is proposed that leads to the prediction of mutants of glutarylamidase that should enable the enzyme to deacylate cephalosporin C into 7-aminocephalosporanic acid.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-11051090, http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-11080627, http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-1390755, http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-13955341, http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-1749775, http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-2993240, http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-4846962, http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-7477383, http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-7607251, http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-7816145, http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-9095194, http://linkedlifedata.com/resource/pubmed/commentcorrection/11742126-9721298
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0961-8368
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
92-103
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Structure-based prediction of modifications in glutarylamidase to allow single-step enzymatic production of 7-aminocephalosporanic acid from cephalosporin C.
pubmed:affiliation
Department of Biophysics, Max-Planck Institute for Medical Research, Jahnstr. 29, D-69120 Heidelberg, Germany. fritz@mpimf-heidelberg.mpg.de
pubmed:publicationType
Journal Article